Viewing on a PDA? Click here to read this email.
Medical Progress Today
mpt home | sign up

Volume 7, Number 33
August 19, 2010



· Medical Device Recalls and the FDA Approval Process, Zuckerman, D. M., Brown, P., Nissen, S. E., Archives of Internal Medicine, 6-14-11
· Patent Reform Gets Key Support in House, Julian Pecquet, The Hill, 6-14-11
· $4.3 Billion Pledged at Vaccine Fund-Raiser, Donald G. McNeil Jr., New York Times, 6-13-2011
· Physicians Leaving Practices for health System Employment, Karen Cheung, FierceHealthcare, 6-13-11

More Headlines >>


· Marco Rubio takes on 'Medi-scare' Marc A. Thiessen, Washington Post, 6-13-11
· 'Vouchercare' Is the Right Name for Medicare Laurence Kotlikoff, Bloomberg, 6-15-11
· Built To Fail: Health Insurance Exchanges Under The Affordable Care Act
· Can Exchanges Help Consumers Get Good Value Insurance? Depends On Where You Live Sabrina Corlette, Kaiser Health News, 6-15-11
· The ObamaCare Bad News Continues Karl Rove, Wall Street Journal, 6-16-11
· ObamaCare's Economic Flaws Doug Holtz-Eakin, Investor's Business Daily, 6-8-11

More Commentary >>


· Why States Are So Miffed about Medicaid Economics, Politics, and the "Woodwork Effect", Benjamin D. Sommers et al., New England Journal of Medicine, 6-15-11
· Auditing Access to Specialty Care for Children with Public Insurance, Joanna bisgaier et al., New England Journal of Medicine, 6-16-11
· Moving Beyond Fee-For-Service: The Case for Managed Care in Medicaid, Michael Ramlet and Carey Lafferty, American Action Forum, 6-14-11
· The New Gold Rush: Prospectors are Hoping to Mine Opportunities in the Healthcare Industry, Health Research Institute, PricewatershouseCoopers, 6-14-11
· Active Purchasing for Health Insurance Exchanges: An Analysis of Options, Sabrina Corlette and JoAnn Volk, RWJF, 6-14-11

More Research>>

Medical Progress Today is published by the Center for Medical Progress at the Manhattan Institute for Policy Research.

For more information about Medical Progress Today, please contact the managing editor, Paul Howard, at, or via telephone at 212.599.7000.

Press inquiries regarding Medical Progress Today can be directed to the Communications Department, at, or via telephone at 212.599.7000.

If you would like to unsubscribe, please reply to us and type "Unsubscribe" in the subject line.

MPT on Facebook Find us on Twitter



Featuring: Edward Abrahams, Stephen Eck, Janet Woodcock, and Ray Woosley

"There are three major hurdles that influence the pace at which this change [to personalized medicine] will occur. . . . . The first is that the regulatory landscape is at best unclear. Second, we don't reimburse for value, we reimburse for quantity. And then thirdly, our educational systems are not set up to encourage change, even absent compelling evidence that there is no alternative."
Edward Abrahams

"We're now seeing many drugs in the mid-to-late stage pipelines of large companies and biotech companies that are the result of the human genome mapping. . . . I think we have to appreciate the fact that from finding the gene to getting the drug is a journey of several years. . . . Equally important, though, is that the genomic revolution has built some tools that will enable personalized medicine."
Dr. Stephen Eck

"No company wants to develop new clinical trial methods; that's not their business. . . . However we need new scientific trial methods, for example to evaluate use of genetic tests along with new drugs that come along, and so we need to come together in different ways to develop that regulatory science."
Janet Woodcock

"Some place where the industry and the regulators and the patients can come together, . . . where these pre-competitive, applied science challenges can be met, is missing right now. We're all doing very good work, but it needs to be increased and it needs to be coordinated."
Raymond L. Woosley


Center for Medical Progress 
Copyright Manhattan Institute for Policy Research
52 Vanderbilt Avenue
New York, NY 10017
(212) 599-7000